ICU Admission Choices – 3.5 min Survey Study from Karolinska Institute – Participate Now
  • This three-and-a-half-minute study – desktop only (not available on mobile/tablet) – explores ICU admission choices. You only have 20 seconds per case!

  • The study is available in several languages— English, French, Italian, Spanish, Swedish, and German, and collects responses from intensive care doctors from around the world. Both doctors undergoing specialization and specialists can participate.

  • The value of admitting the right patient to your ICU is essential, as scarcity of ICU-beds often can be a factor. If we admit patients that are too sick - or too healthy - we will not improve outcomes.

  • Your participation is fully anonymized and ethical/IRB approvals are in place: 2014/756-31/12014-04-22, 2017/1074-32 och 2023-05551-02.

  • Please spread this short survey study to your ICU colleagues.

  • The study closes December 31, 2024

Marvin Zick
ESA at the AMR Symposium Hosted by the Pontifical Academy of Sciences in Vatican

Simone Mancini, GSA Coordinator Regional Sepsis Alliances & Partnership Lead; Dr. Mariam Jashi, GSA CEO; Bill Pullman, actor; Prof. Konrad Reinhart, GSA Founder, President of the Sepsis Stiftung, and member of the ESA Steering Committee.

On 12 November, the European Sepsis Alliance was represented together with the Global Sepsis Alliance and the Sepsis Stiftung at a symposium hosted by the Global Coalition on Aging and Acton Institute at the Pontifical Academy of Sciences in the Vatican.

The meeting was dedicated to discussions on “Solving for Antimicrobial Resistance: A Rising Global Health and Humanitarian Crisis.”

Speakers and panelists of the Symposium included Renzo Pegoraro, the Chancellor of the Pontifical Academy for Life;  Takuko Sawada, Director and Vice Chairperson of the Board, Shionogi; Damiano de Felice, Chief of External Affairs, CARB-X; Konrad Reinhart, Founding President of the Global Sepsis Alliance and President of the Sepsis Stiftung; John Alter  -  CEO, AMR Action Fund; Robin Hiley, Composer & Producer, LIFELINE; Francesca Manno – Director of the Department of Treasury, Ministry of Economy and Finance of Italy; Joel Denis – Director General of the Public Health Agency of Canada; Laurent Muschel – Acting Director General of HERA, European Commission; Atsutoshi Hagino – Delegate of the Japan Ambassador to Holy See; Michael Hodin – CEO of the Global Coalition on Aging and Michael Severance – Director of Acton Institute.

World-renowned American actor and producer Bill Pullman, who has been actively engaged in AMR Advocacy, delivered a special statement and, in parallel to the Vatican Symposium, worked on a documentary on antimicrobial resistance and its threats to humanity. We applaud Mr. Pullman's commitment, reiterating the importance of engaging public figures in awareness-raising on AMR and its critical links to sepsis.

Prof. Konrad Reinhart was requested to deliver a presentation on “Sepsis and the Impact of AMR”. He highlighted that the estimated 4.95 million AMR-associated or attributable deaths are only part of the 13.66 million sepsis-related deaths (see slide below) and called for urgent political support and advocacy for synergizing the AMR and sepsis actions. He noted that after the historic 2017 World Health Assembly Resolution on Sepsis, thanks to the successful leadership of Prof. Karl Lauterbach, Federal Minister of Health of Germany, the call for the synergies of sepsis and AMR policies was integrated into the G7 Health Ministers’ Communiqué under the German Presidency in 2022. However, Prof. Reinhart expressed disappointment that sepsis disappeared in the latest G7 outcomes documents vis-à-vis AMR under the leadership of other G7 countries and asked the relevant government representatives attending the Symposium for action. Prof. Reinhart noted that young children, pregnant women, and older adults over 65 years of age are at special risk of sepsis and septic shock, and efforts on AMR in these high-risk groups also call for stronger harmonization. Finally, he presented highlights of the 2030 Global Agenda for Sepsis that GSA launched at the German Parliament on September 10, as the first multi-year global strategy in the field.

Dr. Mariam Jashi, CEO of the Global Sepsis Alliance, participated in the panel discussions and focused on the following key messages:

  • Importance of hosting the Symposium at the Pontifical Academy on Science as engagement and leadership of religious leaders is essential in raising awareness on global health threats, such as AMR and sepsis

  • AMR-related deaths are part of the sepsis-related deaths, and every political dialogue and declaration on AMR should be linked to sepsis as the human face of the AMR burden

  • The 120 ongoing armed conflicts and the consequent humanitarian crisis involving 362 million children, women, and men increase the risk of infectious diseases and sepsis

  • She presented the 2030 Global Agenda for Sepsis which describes how the 2030 Sustainable Development Goals aspirations will be missed without adequate response to sepsis and AMR.

Simone Mancini, Partnership Lead of the Global Sepsis Alliance, participated in the Q&A Session and, building on the recent civil society meeting in Brussels, addressed the acting Director of HERA with a request to prioritize sepsis in 2025 or 2026 Work plans. He highlighted the statistics that over 3 million people are affected in the EU every year by sepsis, and the cause is linked not only to the AMR but also to Pandemic Preparedness and Response and cross-border threats.

During the discussions, two Hong Kong and Italy delegates shared their sepsis-related stories. They reconfirmed how critical it is to link AMR efforts with sepsis prevention and clinical management.

The estimated 4.95 million deaths associated with or attributable to AMR are only part of the 13.66 million Sepsis-death toll every year and this correlation should be reflected in AMR political declarations, policy, and advocacy documents.

Simone Mancini
ESA and GSA Attend HERA Civil Society Forum and Strengthen Sepsis Network in Brussels

On 8 October, at the occasion of the HERA Civil Society Forum meeting, Global Sepsis Alliance CEO, Dr Mariam Jashi, and Regional Alliances Coordinator, Simone Mancini, organised an outreach programme in Brussels, including encounters with key potential partner organisations, and Brussels based members.

Simone Mancini and Mariam Jashi at the HERA Civil Society Forum meeting.

The Health Emergency Preparedness and Response Authority (HERA) is a directorate-general of the European Commission created to prepare the EU for future pandemics. Its Civil Society Forum, of which the European Sepsis Alliance is a member, is a consultative body composed of organisations active in a broad range of public health policy areas and contributing to the definition of HERA’s strategy and initiatives. At the meeting, Dr Jashi stressed on the need to include sepsis awareness, early detection and treatment in the list of HERA priorities for 2025, considering its close relevance to other priorities, including antimicrobial resistance (AMR). A copy of the 2030 Global Agenda for Sepsis was also well received by HERA representatives at the meeting.

Dr Jashi and Mr Mancini also met with Nicholas Brooke and Amanda Bok, respectively Executive Director and Chief Partnership Officer of The Synergist, a non-profit organization that facilitates multi-stakeholder collaborative programs to address complex societal challenges. They discussed possible ways to maximise the impact of the 2030 Global Agenda for Sepsis and the outreach towards potential supporters and partners. Building on the valuable advices received, the exchange will continue in the coming months.

The GSA team with Frazer Goodwin and Milka Sokolović, EPHA.

The trip was also the opportunity to meet with the European Public Health Alliance (EPHA), one of the major public health organisations bringing together healthcare professional, patient groups, and civil society organisations across Europe. Dr Jashi presented the 2030 Global Agenda for Sepsis to EPHA Director General, Dr Milka Sokolović, and Senior Communications & Advocacy Manager, Frazer Goodwin. The two organisations share similar structure, challenges and ambitions and will continue the dialogue to identify possible areas of collaborations.

Mariam Jashi, GSA CEO, Marianne Haverkamp and Aurica Pria, ESA Patient and Family Support WG Co-Chairs, Simone Mancini, GSA Coordinator Regional Sepsis Alliances.

The day concluded with informal meetings with the Vice President of the GSA, Dennis Kredler, and later with the chairs of the European Sepsis Alliance Patient & Family Support Working Group, celebrating the recent nomination of sepsis survivor Marianne Haverkamp as co-chair. Dr Jashi shared the plan included in the 2030 Agenda to set up a Global Sepsis Patient Group, building on the experience of the ESA WG and of the call to action of the Paris Declaration, recently published on The Lancet.

Simone Mancini
The Lancet Publishes Sepsis Survivors’ Call to European Leaders

The Lancet published the Sepsis Survivor’s call to EU leaders to develop the European Sepsis Plan as the follow-up to the September 9 Sepsis patients summit convened in Paris by Sepsis Stronger Together consortium in partnership with the Global Sepsis Alliance and the European Sepsis Alliance.

The September 9 summit “Revealing the Burden of Sepsis” convened on the occasion of the 2024 World Sepsis Day, brought together Sepsis survivors and grieving families from all over Europe.

The summit focused on sharing good practices across Europe, empowering and creating awareness, inspiring health professionals, and conquering sepsis and its long-term consequences.  

Dr. Mariam Jashi, CEO of the Global Sepsis Alliance, and Simone Mancini, GSA Coordinator of the Regional Sepsis Alliances, joined the event. Mariam Jashi delivered a presentation on the 2030 Global Agenda for Sepsis in the opening session and highlighted the urgency of action against sepsis, at both the EU and global level.

Paris Declaration, a Call to Action to EU public health authorities demanding the development of a European sepsis plan was issued as an outcome document of the event, covering the following 8 recommendations:   

  1. Early detection and treatment

  2. Comprehensive patient information

  3. Proper documentation and registration

  4. Clinical pathway development

  5. National public health campaigns

  6. Educational programs

  7. Universal access to sepsis management

  8. Investments in sepsis research

The Paris Declaration and its 8 recommendations complement the 2030 Global Agenda for Sepsis, as sepsis patients call upon the EU leaders to urgently prioritize Sepsis, accounting for 680,000 deaths in the region every year.

Sepsis claims more lives annually than prostate and breast cancer and HIV/AIDS combined. So why not prioritize this medical emergency and global health threat? Infectious diseases and sepsis do not recognize borders; European countries face similar challenges, so why not share experiences and develop an action plan on a European level?


**‘Revealing the Burden of Sepsis’** was fully patient-driven: patients, grieving families, and patient organizations united in the Sepsis Stronger Together consortium, took the lead. The summit was supported by the Global Sepsis Alliance (GSA), the European Sepsis Alliances (ESA), FHU Sepsis, IHU PROMETHEUS, and 101Fund – an impressive example of patient participation, rarely seen before.

For more information on the Call to Action, please contact Sepsis Stronger Together or check out the Lancet publication.

Marvin Zick
Media Release: 2024 World Sepsis Day Under the Patronage of WHO Director-General and Federal Minister of Health of Germany

For the 13th year, the global health community is coming together to commemorate World Sepsis Day on September 13, 2024 (WSD 2024).

WSD 2024 marks the beginning of a new chapter in the global fight against sepsis as the Global Sepsis Alliance launches the very first multi-year strategy – the 2030 Global Agenda for Sepsis.  

Building on the successes of immunization, AIDS, and other programs, the 2030 Global Agenda envisions making sepsis the next major success story in global health. This vision inspires the theme for World Sepsis Day 2024: “Next Success Story in Global Health: Could It Be Sepsis?”


Patronage of 2024 World Sepsis Day

The European and the Global Sepsis Alliance are honoured that Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), and Prof. Dr. Karl Lauterbach, Federal Minister of Health of Germany, have extended their official patronage to World Sepsis Day 2024. The video message from Dr. Tedros Ghebreyesus and the written message from Federal Minister Lauterbach are inspiration for our further, even stronger fight against sepsis.

BMG/Thomas Ecke

Undetected or untreated sepsis is a death sentence. This is why sepsis needs to be classed as an acute emergency. If medical treatment is not provided in time, the body’s immune response can cause irreversible harm to the organs. Claiming 85,000 lives a year, sepsis is the third-most frequent cause of death in Germany. Twice as many people die in hospitals from sepsis than from stroke and heart attack combined. While many people are aware of the signs of a stroke or heart attack, too few people know about sepsis.

Everyone should therefore familiarize themselves with the potential symptoms of sepsis so that when they themselves or others around them are feeling severely ill, they might also think of sepsis.

Among the population as a whole but also among medical staff sepsis must be given higher priority so it is considered earlier on when symptoms are severe.

World Sepsis Day, whose patronage I gladly took on, is also helping to raise awareness about sepsis. In Germany, we are also working to boost awareness of the symptoms of sepsis with the “Germany recognizes sepsis” campaign.

Sepsis can also be the result of antibiotic treatment becoming ineffective on account of the germs having developed resistance. Measures to ensure appropriate use of antibiotics also help to prevent instances of sepsis. This is why sepsis is one of the focal points of the new German Antibiotic Resistance Strategy.

The sepsis resolution adopted by the World Health Assembly in 2017 calls on every country to take up the fight against sepsis by means of improved diagnostics, appropriate use of antibiotics as well as targeted knowledge transfer.
At my initiative, in 2022 the G7 Health Ministers once more pledged their support to the cause. Here, collaboration and sharing best practices are vital. And that is what the World Sepsis Day stands for.

Thank you all for your work in detecting and preventing sepsis. I hope that all the initiatives and events of this year’s World Sepsis Day reach the broadest audience possible.
— Prof. Dr. Karl Lauterbach, Federal Minister of Health, Germany

About the 2030 Global Agenda for Sepsis

The 2030 Global Agenda for Sepsis is the first global strategy developed under the leadership of the Global Sepsis Alliance, with the engagement of 70 partner and member organizations from GSA and Regional Sepsis Alliances across Africa, Asia-Pacific, the Caribbean, the Eastern Mediterranean, Europe, Latin America, and North America.

The Global Sepsis Alliance officially launched the 2030 Global Agenda for Sepsis at the German Parliament on September 10, 2024.  This historic event was led by the Chair of the Global Health Sub-Committee in the German Bundestag. It was held in partnership with the UNITE Parliamentarians Network for Global Health, the Virchow Foundation, and Sepsis Stiftung.

Sepsis survivors and families who have lost loved ones to sepsis played a crucial role in the development of this document. Their advocacy has led to significant changes in countries such as the United States, Belgium, and France. They are ready to become even stronger advocates, aiming to reduce sepsis-related deaths by at least 2 million annually before 2030.

The 2030 Global Agenda highlights the significant human, societal, and economic burden of sepsis and underscores that achieving the 2030 Sustainable Development Goals (SDGs) will require stronger action against sepsis.

  • Sepsis remains a major global health issue, accounting for 1 in every 5 deaths worldwide and affecting 48.9 million people. Newborns, children under the age of 5, women, immunocompromised individuals, and older adults are particularly vulnerable to this medical emergency.

  • Every year, sepsis causes at least 11 million deaths, yet it remains largely invisible in global health discussions and frameworks. Recent estimates suggest that sepsis claims 13.7 million lives annually.

  • Of the estimated 13.7 million sepsis-related deaths each year, approximately 4.95 million are associated with antimicrobial resistance (AMR). Yet, compared to the critically important challenge of AMR, sepsis continues to receive disproportionately low political attention and investments. 

  • With 5.7 million maternal sepsis cases and 2.9 million deaths among children under five annually, achieving health-related SDGs for 2030 is unattainable without fundamental changes in the global response to sepsis. Enhancing sepsis responses can also accelerate progress toward eight additional SDGs by addressing gender inequality, improving universal health coverage (UHC), and strengthening pandemic preparedness.

  • The economic impact of sepsis is substantial. Sepsis accounts for 2.65% of healthcare budgets, with a median hospital cost of €36,191 per septic patient.

  • Sepsis survivors often face long-term consequences and require specialized care and rehabilitation, which is frequently unavailable even in countries with robust healthcare systems. 

  • Seven years after the adoption of the historic World Health Assembly Resolution, only 15 countries—less than 10% of UN Member States—have developed national action plans or policies for sepsis.

Finally, the document outlines a shared vision for making sepsis the next success story in global health through the following actions.

  • Urgent and Adequate Political Attention: Sepsis affects nearly 50 million people annually and requires immediate political attention and investment. This includes support from national governments, international development aid, global public-private partnerships (such as GAVI and the Global Fund), philanthropic foundations, the private sector, and innovative funding mechanisms like UNITAID.

  • Whole-of-Society Approach: It is crucial to continuously raise awareness about sepsis within families and communities, emphasizing that it is a medical emergency that demands immediate care. Every member of our communities has a role in this global fight. Actions should be taken at national, regional, and international levels, ranging from policy and health system strengthening to media outreach and community-level activities.

  • Innovative Solutions: We need new and more effective vaccines, diagnostic tools, antibiotics, immunomodulatory therapies, and rehabilitation resources for sepsis survivors. Additionally, artificial intelligence (AI) tools should be developed to detect sepsis early and provide timely, life-saving treatment.

  • Improving Data and Accountability: Sepsis-related data is limited, particularly in low- and middle-income countries, which bear 85% of the global sepsis burden. There is a need for more comprehensive and high-quality data, along with stronger accountability mechanisms for governments and other key stakeholders.

  • Preparedness for Future Threats: Based on the COVID-19 experience, future pandemics will increase sepsis incidence and mortality. The 120 ongoing armed conflicts globally, 362 million children in humanitarian crises, and climate change also highlight the need for better protection of civilians, humanitarian workers, and military/peacekeeping personnel from increased risks of sepsis.


Join Our Efforts in Making Sepsis the Next Success Story in Global Health

With the 2030 Global Agenda for Sepsis, we have a unique opportunity to make sepsis the Next Success Story in global health and save millions of children, women, and men from this global threat.

The document has already received technical inputs from WHO Geneva and Regional Offices and endorsements from 29 organizations across Africa, Asia-Pacific, the Caribbean, Eastern Mediterranean, Europe, Latin, and North America.

The Global Sepsis Alliance is calling its members, partners, and multiple stakeholders to support the 2030 Global Agenda as the common roadmap to saving lives from unnecessary deaths and disabilities.

Interested organizations from public, private, academic and civil society sectors can endorse and support the implementation of the document by contacting us.

Please join us in celebrating the 2024 World Sepsis Day and supporting the successful implementation of the 2030 Global Agenda for Sepsis.


More About the 2024 World Sepsis Day Theme

This year’s theme embodies two key messages. The global health community is well-equipped with proven knowledge and the shared vision outlined in the 2030 Global Agenda to make the global sepsis fight the next success story. The question “Could It Be Sepsis?!” has proven effective in raising awareness, building capacity and saving thousands of lives in countries such as Australia and the United Kingdom. Our goal is to expand these local successes to a global scale.


Download Press Release

You can download this media release as a PDF here.


Media Contact

For all inquiries, please contact Simone Mancini, Partnership Lead at the Global Sepsis Alliance.

Simone Mancini
The Lancet publishes series on paediatric sepsis

No age group has as high a risk to develop sepsis as children during the first years of life. Of the globally estimated 50 annual million sepsis cases, approximately half occur in neonates, children, and adolescents. This results in a devastating burden to society in terms of mortality, morbidity, long-term sequelae, and costs. Yet, this burden stands in stark contrasts to the degree of evidence and amount of resources dedicated towards preventing, diagnosing, and treating sepsis in children.

It is therefore highly timely that The Lancet has commissioned a Series on Paediatric Sepsis. Written by a group of paediatric sepsis experts from all around the world, the Series provides state-of-the-art insights into the current state, gaps, and outlines a roadmap to tackle sepsis in children. The four papers of the Series are available freely online, and cover:

i) Epidemiology of sepsis in children, mortality and short-term burden, long-term outcomes, and the relationship with Sustainable Development Goals.

ii) The unique susceptibility to sepsis of the paediatric host, current management strategies and controversies, and a roadmap towards future research.

iii) Barriers, gaps, and lessons learnt from quality improvement programs targeting sepsis in children, and directions for future quality improvement initiatives.

iv) Innovation in digital approaches to measuring, recognizing, and managing sepsis.

The Series includes four specific papers, two Lancet profiles, an Editorial, and a podcast conversation with Prof. Nelson Sánchez-Pinto and ESA Steering Committe member Prof. Luregn Schlapbach.

At the occasion of World Sepsis Day, and following the release of the new Phoenix Criteria for paediatric, sepsis earlier this year, we commend The Lancet for such an important initiative, focusing on such an important aspect of Sepsis. Awareness, research and improved treatment can save the lives of millions of children worldwide. We are also grateful to all authors for their excellent work, including ESA Steering Committe member Prof. Luregn Schlapbach.

Simone Mancini
Live now: ESA Chair Prof. Giamarellos co-hosting the 2024 World Sepsis Day Symposium "The Immune System: The Double-Edged Sword in the Fight Against Sepsis"

On the margins of the 2024 World Sepsis Day, the Global Sepsis Alliance and the European Sepsis Alliance are joining the Sepsis Stiftung in convening an international symposium on the role of the immune system in the fight against sepsis. The event is also supported by the Max Planck Institute for Infection Biology, the Berliner Medizinische Gesellschaft, and the Germany Recognizes Sepsis campaign.

The international symposium will focus on the critical importance of the immune system in effective prevention and treatment of sepsis. Throughout two main sessions of the symposium – vaccination and immunomodulation – 8 globally renowned speakers will share their perspectives and recommendations on the potential of vaccination for sepsis prevention, lessons learned for vaccine development, how to combat distorted medical information in the digital age, personalized immunotherapy in for septic patients, and much more.

We are especially proud to announce that the symposium is under the patronage of Dr. Tedros Adhanom Ghebreyesus, Director-General WHO, Prof. Dr. Karl Lauterbach, Federal Minister of Health, Germany, and Kai Wegner, The Governing Mayor of Berlin, Germany.

Simone Mancini
Register and Join the Sepsis Survivor Community in Paris for the September 9 Conference “Revealing the Burden of Sepsis”

The European Sepsis Alliance (ESA) and the Global Sepsis Alliance (GSA) are proud to support Sepsis survivors in convening the first patient-led conference in Europe “Revealing the Burden of Sepsis”. The event will take place at the French Economic, Social and Environmental Committee (CESE) in Paris on 9 September.

This unique patient-driven conference will bring together the international sepsis community and will put at the centre of the discussion the profound impact of sepsis on patients, survivors, and their families. 

The presentations will share testimonials from sepsis survivors and families affected by this medical emergency, as well as experts’ perspectives on how to increase awareness globally and promote best practices in prevention, diagnostics, treatment and care for Sepsis.

The Global Sepsis Alliance CEO, Dr Mariam Jashi will join the conference in person and present the 2030 Global Agenda for Sepsis (the first multi-year global strategy), scheduled to launched on September 10 at the German Parliament.

Dr. Mariam Jashi - CEO, Global Sepsis Alliance.

“The 2030 Global Agenda for Sepsis calls for active engagement of patients and families in awareness-raising and advocacy efforts for national policies, patient-focused protocols, novel vaccines, diagnostics, therapies and AI solutions for Sepsis. I applaud the organisers and participating patient organisations for this benchmarking event. We hope that the Paris conference and its outcome Call-for-Action from Sepsis survivors will help policymakers in the European region and globally to take relevant actions for reducing the heavy burden of Sepsis on individuals and broader societies”, said Dr. Mariam Jashi , CEO of the Global Sepsis Alliance.

To register and participate, either in-person or online, click on the button below.

Simone Mancini
Save the date: 25-27 September, ESA and ESCMID co-hosts course on precision medicine in sepsis

The course, organised by the European Sepsis Alliance together with the ESCMID Study Group of the Critically Ill Patients, aims to share knowledge and provide a holistic approach for the management of all aspects of sepsis. At the end of the course, attendees will have gained knowledge on an integrated approach towards sepsis patients, including:

  • Use of new antimicrobials for multidrug resistant Gram-negative pathogens.

  • New insights on diagnosis and treatment, early recognition of sepsis and classification using sub-phenotypes.

  • Use of biomarkers to guide diagnosis and management, treatment guidance.

  • Use of molecular diagnosis, and adjunctive treatments.

  • Design and conduct of translational research in the field.

  • The need to build awareness for sepsis.

The course will take place in Athens, Greece. For further information, registration and logistics details, please consult the ESCMID website via the button below.

Simone Mancini
ESA Salutes First Report on Sepsis in Belgium, Leading to a National Plan

The European Sepsis Alliance is proud to celebrate a historic achievement in the fight against sepsis in Belgium. On Friday, May 31, the first-ever comprehensive report on sepsis has been officially handed over to the Belgian Minister of Health, Frank Vandenbroucke.

This landmark event was made possible also through the dedication and efforts of ESA member Sepsibel, and the remarkable contribution of sepsis survivor Ilse Malfait. Her tireless dedication, courage, and advocacy have been instrumental in bringing the urgent issue of sepsis to the forefront of national health discussions.

The journey to this achievement began with a powerful TV report on Belgian national television VRT, which highlighted the devastating impact of sepsis. In response, Minister Vandenbroucke mandated Prof. Erika Vlieghe to produce a report for the preparation of a national action plan. Prof. Vlieghe swiftly mobilized a group of 62 experts from different disciplines, including physicians, nurses, physiotherapists, and sepsis survivors, who produced the report in just six months. We extend our heartfelt congratulations to Prof. Vlieghe for her exceptional leadership and to all the experts and survivors who contributed to this groundbreaking report.

The European Sepsis Alliance has been an early supporter of Sepsibel since its inception. Our collaboration has been driven by a shared goal to enhance sepsis awareness, improve patient outcomes, and ultimately save lives. Sepsibel’s rapid mobilisation and effective advocacy efforts, exemplified by the work of Ilse Malfait, have been truly inspiring. Her personal journey as a sepsis survivor has brought a powerful and relatable voice to the cause, helping to raise awareness and drive change at a national level. Ilse shared her story at the GSA World Sepsis Day event on September 12, 2023.

Reflecting on this historic milestone, Prof. Evangelos Giamarellos-Bourboulis, Chair of the European Sepsis Alliance, stated: “We congratulate Sepsibel, Ilse Malfait, Prof. Vlieghe, and Minister Vandenbroucke for achieving this historic milestone in record time. The swift production of this report within just six months is a testament to the dedication and collaborative spirit of everyone involved. This achievement will undoubtedly pave the way for future advancements in sepsis awareness and management.”

As we celebrate this significant achievement, we remain focused on the future. The European Sepsis Alliance will continue to support Sepsibel as we work towards the implementation of a national sepsis plan in Belgium.

We extend our deepest gratitude to all who have contributed to this milestone and look forward to continuing our collaborative efforts in the fight against sepsis.

THE REPORT AT A GLANCE

The submission of this report is not just an achievement in itself, but it also marks the beginning of a crucial process. The ultimate objective is to develop a national sepsis plan for Belgium, a comprehensive strategy that will ensure better prevention, recognition, and management of sepsis across the country. This first step lays the groundwork for significant improvements in public health and patient care.

The Belgian Sepsis National Action Plan (Be-SNAP) focuses on seven key areas to combat sepsis:

Awareness and Knowledge:

  • Increase public awareness and understanding of sepsis.

  • Educate healthcare providers on early recognition and management of sepsis.

  • Develop a National Sepsis Foundation to serve as a hub for educational materials and support.

Prevention and Safeguarding Antimicrobials:

  • Strengthen healthcare access, particularly for vulnerable populations.

  • Promote vaccination and infection prevention measures.

  • Implement antimicrobial stewardship programs to prevent the misuse of antibiotics and combat antimicrobial resistance.

Early Warning Systems:

  • Develop and validate sepsis screening tools for use in various healthcare settings, including long-term care facilities, primary care, and hospitals.

  • Implement early warning scores and rapid response systems to detect and manage sepsis promptly.

Early Adequate Treatment:

  • Ensure timely administration of antibiotics and supportive care.

  • Provide large-scale education for healthcare providers on basic and advanced sepsis treatment.

  • Guarantee 24/7 availability of specialized care teams for severe cases.

Care Trajectory for Sepsis Survivors:

  • Develop a multidisciplinary rehabilitation pathway addressing physical, psychological, and neurological needs.

  • Ensure seamless transition and follow-up care from hospital to home.

  • Provide education on post-sepsis syndrome and support for survivors and their families.

Ethical Considerations and Advanced Care Planning:

  • Educate healthcare providers and the public about advance care planning and critical illness outcomes.

  • Support general practitioners and specialists in implementing advance care planning.

  • Ensure the availability of advance directives for all relevant healthcare providers.

Research and Surveillance:

  • Establish a Belgian sepsis registry to collect detailed data on sepsis cases.

  • Promote sepsis research and international collaboration.

  • Develop real-time analysis and reporting systems to monitor sepsis trends and improve patient care.

These pillars aim to reduce the incidence and impact of sepsis in Belgium through comprehensive strategies involving prevention, early detection, effective treatment, and continuous support for survivors. The plan emphasizes collaboration among healthcare providers, researchers, and patient advocacy groups to achieve these goals.


Simone Mancini
How to Join the 2024 World Sepsis Congress Spotlight on April 23

The 2024 World Sepsis Congress Spotlight is almost here – starting Tuesday, April 23 at 09:00h Central European Summer Time, free of charge and entirely online.

Participating in the 2024 WSC Spotlight is incredibly easy – just click on the button below and enter your email if you are registered already. If not, simply register for the congress here before joining the livestream.


ABOUT THE 2024 WSC SPOTLIGHT

Throughout 9 distinctive sessions, globally renowned clinicians, researchers, experts, and thought leaders will cover the need for early diagnosis and treatment of sepsis in surgical patients, data, AI, and predictive modeling in sepsis, how hypervolemia increases the mortality rate in sepsis, the role of biomarkers, detecting sepsis in ventilated patients, pediatric sepsis, including the new ‘Phoenix Criteria’, as well as personalized approaches to sepsis management.

ESA Chair Evangelos J. Giamarellos-Bourboulis, and ESA Steering Committee members Konrad Reinhart and Luregn Schlapbach will also contribute to the programme with talks on biomarkers, the newly adopted Phoenix criteria, and sepsis advocacy.

This free online congress is designed for healthcare workers, healthcare providers and funders, healthcare authorities, policymakers, patient families, survivors, and industry professionals.

Don't miss this opportunity to gain insights and knowledge from the world's leading sepsis experts. Register now and be part of this global effort to improve sepsis outcomes for patients everywhere. For more information on the program, speakers, and time zones, and to register for free, please visit wscspotlight.org.

Simone Mancini
7th ESA Annual Meeting Report: A Call for Europe's Leadership on Tackling Sepsis

Hans Kluge, Regional Director, WHO Europe

Prof. Evangelos Giamarellos-Bourboulis, ESA Chair

“Europe is uniquely positioned to spearhead efforts against sepsis. Leveraging cutting edge research, fostering international collaboration and advocating for comprehensive health policies, we can catalyse significant progress in sepsis prevention, diagnosis and treatment”. With this strong message, WHO Regional Director for Europe, Hans Kluge opened the 7th Annual Meeting of the European Sepsis Alliance, reiterating the continued support of WHO and calling on European leaders to join the fight against sepsis.

ESA Annual Meetings are unique opportunities to take stock of the progress of sepsis policy, research and advocacy. We are proud and honoured to have assembled such a distinct panel of speakers, each bringing their unique perspective, contributing to describing the current situation of sepsis care in Europe.
Philippe Roux confirmed the indirect contribution of EU policies through the ongoing focus on reducing the burden of antimicrobial resistance (AMR). The recently approved European Council recommendations on AMR, besides encouraging education on sepsis, will entail European guidelines on infection prevention and control and on antimicrobial stewardship for the treatment of major infections, to the development of which ESA has indicated its interest and availability. Furthermore, the Horizon Europe programme has already provided a total of €35 million support to sepsis-focused grants.

Mariam Jashi, CEO, Global Sepsis Alliance

However, despite the encouraging progress, and the staggering data shared by the speakers, concern was raised that sepsis is still not a priority in European health policy. Both the Global Sepsis Alliance (GSA) CEO, Dr Mariam Jashi, and the GSA founder, Prof. Konrad Reinhart, highlighted the disproportion between the policy focus and financing for AMR, compared to sepsis. Less than 10% of UN member states have prioritised sepsis in their health systems, highlighted Dr Jashi, who also stressed that the 4.95 million deaths attributable or associated with AMR are only part of the 13.66 million sepsis deaths. “Sepsis should be positioned in the global health agenda and in the mainstream of the global health architecture”, she exhorted.

Hon. Nathalie Muylle, Chamber of Representatives, Belgium

The meeting was also an opportunity to learn from countries that have prioritised sepsis. Belgium, currently holding the Presidency of the European Council, was deliberately well represented, also considering the significant progress and concrete steps initiated by sepsis survivor Ilse Malfait and the survivor group SEPSIBEL, who succeded to convince Health Minister Frank Vandenbroucke to commission a sepsis national plan. Ilse is supported in Belgium by far-sighted politicians such as Nathalie Muylle, who explained why in her view it is so crucial to prioritise sepsis: “It is more than just ticking another box in the long list of health priorities. It is about tackling a widespread threat that […] does not choose its victims and does not discriminate”. Muylle also enunciated the key elements of the upcoming Belgian plan, such as data collection, education, awareness campaigns, guidelines for early diagnosis and treatment, and specialised support for sepsis survivors.

Simone Mancini, Nora Lüthi, Edoardo De Robertis, Ron Daniels, Ilse Malfait

Similar elements were also shared in the first panel, where Dr Nora Lühti from Switzerland and Dr Ron Daniels from the UK helped participants understand what it takes to set up a national plan prioritising sepsis nationally. The interventions confirmed that survivors and families can be a powerful trigger for action in a country, as was the case in the UK or Belgium. The leadership of dedicated professionals was instead the main vector of change in other countries like Switzerland. Prof. De Robertis highlighted that tools and knowledge about sepsis are available, however probably only few scientific societies (i.e. intensivists, anaesthesiologists), focus on sepsis while this condition has a horizontal nature and can happen especially outside healthcare facilities. Furthermore, the correlation with AMR and pandemic preparedness must be further explored by healthcare professionals. Prof. De Robertis also stressed on the need to provide support to survivors, which is one of the priorities brought up by Ilse Malfait. Ilse shared once more her poignant story and said she was lucky, as she had “only” the limbs amputated, and also because she has access to a good rehabilitation therapy, but this is not the case for all patients in Belgium, who too often suffer from neurological problems too, without an adequate post-sepsis care. Information and support to sepsis survivors must be improved and widely disseminated, as it is the case for other diseases such as cancer. The issues of improving data collection, personalised treatment, equity in access to healthcare were also discussed by panellists and the audience.

Ulrika Knutsson, Ron Daniels, Ann Gills, Aurica Pripa

Aurica Pripa, ESA Patient and Family support Working Group, shared her dream of a society where sepsis is the most prevented (and no more preventable) cause of deaths, where awareness, treatment and support to patients and their families contribute to improve patient outcome. The key message of the panel “Understanding sepsis: from silos to a common fight” was that the whole society must be involved in improving sepsis awareness, sepsis cannot be an issue of only patients and healthcare professionals, but media, industry, charities and lay persons must all be involved. Ron Daniels once more stressed on the need to change the narrative about AMR, that is something concrete happening today, and hitting certain populations more than others. However, AMR does not kill people, but untreatable infections and sepsis do. Ann Gils, from the Belgian cancer organisation Kom Op Tegen Kanker, stressed on the need to break silos between sepsis and other diseases like cancer, that have much more visibility and support. Finally, Shahrzad Kiavash’s witness, similarly to the one of Ilse, confirmed the need to improve sepsis awareness as her life could have been different right now if the doctors attending her in the first hours of her sepsis experience would have acted adequately.

Marco Cavaleri, European Medicines Agency

Konrad Reinhart, Antonio Artigas, Evangelos Giamarellos-Bourboulis, Adam Linder

The last session discussed the challenges of setting up and running research networks on sepsis, ARDS and related areas, and their critical value contributing to the preparedness of Europe for the next pandemic. Prof. Giamarellos raised the importance for research networks of involving physicians beside qualified research centres to make sure that results are broadly embraced and adopted in sepsis treatment, as for the case of biomarkers. Prof. Artigas went even further by suggesting including non-physician investigators in research networks for pre-clinical studies, benefiting from their knowledge and scientific approach. The importance of networks was also stressed by Prof. Artigas, if Europe wants to compete with the US. The point was echoed by Marco Cavaleri, who stressed on the importance of European clinical trial networks which should be well funded through European money (via HERA for example) or national funds, to operate effectively and continuously. Those networks should also involve patients, ARDS and sepsis experts, identify products, biomarkers and phenotypes that could help us be prepared for the next pandemic. Regarding the issue of comparability of data, Prof. Linder also suggested using the ongoing national plans to collect harmonised clinical data.

Despite realising that sepsis still needs to gain visibility, that awareness must be continuously improved and that the scientific knowledge still investigated, the event concluded with a shared feeling of empowerment, as participants realised the progress since the inception of ESA in 2018. We are today in the right direction of a strong European sepsis agenda, jointly led by advocates, patients, physicians, industry and policymakers.

The recording of the entire event is available below and on YouTube.

Simone Mancini
Join the Free Livestream Now – 7th Annual Meeting of the European Sepsis Alliance in Brussels

Update March 18, 2024: The event has concluded, thank you for joining. You can rewatch it above.


Our 7th Annual Meeting will go down today, Monday, March 18, 2024 – and it’s not too late to join the free livestream on YouTube or embedded above.

We start at 11:00h Brussels Time (click here to see your time zone) and we have an amazing line-up of speakers for you, including sepsis survivors, policymakers, advocates, sepsis experts, and more. In addition to hearing thought-provoking presentations, we are super excited to host 3 distinct panel discussions featuring inspiring panelists and intriguing discussions.

So, what are you waiting for? Join the livesteam now and interact with us and other viewers, directly in the chat on YouTube.

In case you can’t make it live, the event will be available for recap as soon as it has concluded, at the same link and embedded above.

Marvin Zick
Register Now – WSC Spotlight: Unmet Need in Sepsis Diagnosis and Therapy – April 23, 2024

Niranjan ‘Tex’ Kissoon, President of the Global Sepsis Alliance, and Louise Thwaites and Michael Wong, Program Chairs, are honored and excited to officially open the registrations for the 2024 WSC Spotlight on April 23, 2024.


We are thrilled to extend a warm welcome to thousands of colleagues joining us from across the globe for yet another exceptional opportunity to delve into and exchange insights on the newest trends, advancements, and innovations in the field of sepsis practice and research.
— Niranjan ‘Tex’ Kissoon, President GSA

Dr. Niranjan ‘Tex’ Kissoon

As always, the 2024 WSC Spotlight will be free of charge and completely virtual, enabling broad participation from all parts of the world. For years, the WSCs have engaged between 8,000 and 20,000 scholars and practitioners from more than 180 countries.

Over one day and 9 highly relevant sessions, over 40 internationally renowned speakers, panelists, and moderators will address the role of AI, predictive modeling in sepsis, the need for early diagnosis and treatment of sepsis in surgical patients, the role of biomarkers, personalized approaches to sepsis management, how hypervolemia increases the mortality risk in sepsis, community programs to prevent and diagnose sepsis, and much more.

Whatever topic and speaker is most relevant to you, the Program Chairs Louise Thwaites, Board Member of the GSA and APSA, and Michael Wong, Founder and Executive Director of PPAHS, are excited to welcome you on April 23.

Dr. Louise Thwaites

Michael Wong

Just as with our previous World Sepsis Congresses in 2016, 2018, 2021, and 2023, and WSC Spotlights in 2017, 2020, and 2022, this free online congress brings together highly ranked representatives of international and national healthcare authorities, non-governmental organizations, policymakers, patients, patient advocacy groups, clinical scientists, researchers, and pioneers in healthcare improvement.

Marvin Zick
Register for the 7th Annual Meeting of the European Sepsis Alliance, 18 March 2024

Evangelos Giamarellos-Bourboulis, chair of the European Sepsis Alliance, is honored and excited to invite you to join the 7th Annual Meeting of the ESA in Brussels on March 18, 2024.

The whole ESA Steering Committee is delighted to welcome in person and online our friends and stakeholders, to exchange learnings and identify challenges and solutions for the fight against sepsis in Europe. We look forward to hearing the perspectives of prominent leaders on the advances in research, policy, and advocacy.
— Evangelos Giamarellos-Bourboulis, Chair of the ESA

The event “Is Europe ready to lead the Global Agenda on Sepsis?” will take place on Monday, March 18, 2024, in Brussels, with registrations now open for both in-person attendance and the free live stream.

2024 is a year of change in many aspects: sepsis is finally being understood by global leaders as a health emergency that must be prioritized and deserves urgent action, if we want to effectively tackle other global priorities such as AMR, pandemic preparedness, patient safety, and health equity.

The European elections on the horizon provide a unique opportunity to include and prioritize sepsis in a renewed European health policy agenda.

Join policymakers, experts, and patients for an engaging discussion that will explore progress, challenges, and successful ways forward in the fight against sepsis in Europe.

Simone Mancini
ESA Steering Committe member and GSA VP Ron Daniels on Updated UK NICE Guidelines for Sepsis

On January 31, the UK National Institute for Health and Care Excellence (NICE) released updates to the Sepsis Guidelines (NG51).

The guidance is attended for people with suspected sepsis, their families and carers, as well as healthcare professionals working in primary, secondary, and tertiary care.  The latest edition of the document includes updates to the risk stratification of adults, appropriate timing for antibiotic administration for different risk categories, and the reassertion of the importance of clinical judgment. 

Ron Daniels, the Vice President of the Global Sepsis Alliance and the Founder and CEO of the UK Sepsis Trust (UKST):

“We particularly support that the update continues to recommend the identification of high-risk factors, whilst reinforcing the importance of clinical judgment to prevent the injudicious use of antibiotics. The recommendation for GPs and ambulance services to consider how they give antibiotics to people who are at high risk of sepsis is increasingly relevant as transit times increase and could be potentially transformational in terms of patient outcomes.”

— RON DANIELS, GSA VICE PRESIDENT

Based on the new NG51 Sepsis Guidelines, the UK Sepsis Trust has ensured relevant updates to its clinical tools for healthcare practitioners.

Ron Daniels further notes that the revised guidelines present an opportunity to deliver a coordinated and cohesive approach to the recognition and management of sepsis across the National Health Service (NHS).

Simone Mancini
ESA Mourns the Loss of John Ryan, Early Supporter of the Fight Against Sepsis in Europe

The ESA is saddened to learn about the passing of John F. Ryan, former Deputy Director General of DG SANTE, European Commission.

We are privileged to have hosted Mr Ryan at two of the ESA Annual Meetings. He listened with genuine attention and interest to ESA and contributed with clear messages and vision to connect sepsis with other priorities in the European Commission’s agenda. His presence alone was an encouraging sign for ESA and certainly contributed to raise awareness about sepsis amongst European policymakers and stakeholders.

John Ryan was known and appreciated by the entire European health community. ESA joins the chorus of condolences of many other professional organisations. Most importantly, our thoughts are with his family, relatives and close ones.

Simone Mancini
Post-Sepsis Syndrome: a Compelling Review Analyses the Long-Term Effects of Sepsis

Post-sepsis syndrome (PSS) is defined as a constellation of long-term physical, medical, cognitive, and psychological issues following sepsis recovery that puts survivors at risk for hospital readmission, and is associated with a reduction in health and life span. In a review recently published in Infection and Drug Resistance, researchers have delved into the current knowledge of post-sepsis syndrome, shedding light on the lingering consequences of sepsis that extend far beyond the initial illness. The article explores the aftermath of sepsis and the challenges faced by individuals on their road to recovery.

“This review underscores the significance of ongoing efforts in the field of sepsis management. As we strive to enhance survival rates, it is equally imperative to address the long-term impact on those who overcome sepsis”, says Prof. Adam Linder, ESA Steering Committee member, Coordinator of the Research Working Group, and co-author of the article.

PSS isn't merely a transient phase, it encompasses a range of physical, cognitive, and psychological symptoms. Survivors may deal with fatigue, muscle weakness, and joint pain, affecting their ability to resume normal activities. Cognitive impairments, such as memory loss and difficulty concentrating, pose additional hurdles, impacting both professional and personal aspects of life.

Crucially, the article emphasizes the importance of healthcare providers and patients recognizing these persistent effects. Increased awareness is vital for tailored rehabilitation strategies and comprehensive support systems that address the multifaceted nature of PSS.

For physicians, understanding PSS means acknowledging the complexity of post-sepsis recovery and actively involving survivors in their care plans. Equipping healthcare professionals with the knowledge to identify and manage PSS ensures a more holistic approach to post-sepsis care.

The European Sepsis Alliance remains committed to disseminating information that empowers both medical professionals and individuals affected by sepsis, fostering a collective approach towards comprehensive and compassionate care. The World Health Assembly 70.7 Resolution urges UN member states to integrate sepsis in their national health systems. ESA believes that patient follow-up and survivor support should be an integral part of national sepsis plans, because of the huge impact of PSS on healthcare systems and on the society at large. After publication of an earlier study on the high burden of post-sepsis morbidity, the ESA Patient and Family Support Working Group issued a position paper calling for increased focus on post-sepsis syndrome and asking that patient follow-up must be carried out routinely, at or after hospital discharge, must be multidisciplinary, as patients can be affected by multiple diagnoses after sepsis, and financially sustained by healthcare systems and insurers. 

Simone Mancini
Ilse Malfait, Championing the Fight Against Sepsis in Belgium 

Ilse Malfait’s story is one of incredible human strengths, resilience, and perseverance. In May 2020, Ilse's life took an unexpected turn when she discovered a lump in her right breast. The initial plan involved chemotherapy, breast-conserving surgery, and radiation to combat the aggressive tumor. However, fate had a different agenda. "Four days after my first chemo treatment, severe stomach pain gripped me at night, leading to a rush to the hospital," Ilse recounts.

Her medical journey had unforeseen complications. "A few months earlier, I faced intestinal problems, and now it turned out I had an intestinal perforation. The emergency operation went well, but what followed was beyond anyone's expectations," she shares.  The evening after the intestinal operation, Ilse had so much stomach pain that she thought she was going to die. Increasing the pain medication did not help. Breathing problems, nausea, very low blood pressure, an increased heart rate, fever, and fainting: her condition deteriorated so much that she ended up in intensive care.

Ilse encountered septic shock, a diagnosis that surfaced only thirty hours after the first symptoms, bringing significant consequences. Originally slated for a week, her hospital stay stretched into a staggering 487 days, encompassing intensive care, medical oncology, and a year in the rehabilitation center. "I don't remember anything for the five or six weeks after the operation; I was in a coma," Ilse reflects. Transported to a university hospital in Ghent, her survival chances appeared slim. However, the dedication of the intensive care team saved her life. Unfortunately, the aftermath of sepsis and the medication led to insufficient blood flow, resulting in the amputation of her fingers and lower legs.

The initial four months post-sepsis are defined by Ilse as sheer survival. She faced excruciating pain, compounded by the inability to receive necessary breast cancer treatment due to her weakened heart. The sepsis forced a change in plans – chemotherapy was halted, and a breast-conserving procedure became impossible, ultimately leading to a complete mastectomy. A breathing tube deprived her of speech, food, and drink. The removal of the tube marked a turning point, allowing Ilse to reconnect with her family, express gratitude to the medical team, and savor the simple joys of conversation and meals.

The path to recovery was daunting, with intensive rehabilitation paving the way for Ilse to walk again with prostheses. The transition from a wheelchair to walking was a monumental feat, marked by challenges such as pain and difficulty reaching household items.

As Ilse's range expanded gradually, she faced the delicate balance of not overexerting herself, as stepping caused wounds on the stumps of her legs. Phantom pain in her legs, waking her up at 4 am every night, adds to the ongoing challenges. The struggle continues, but Ilse remains determined to push through. Ilse's cancer check-ups since then have been positive, and she has been declared cancer-free. However, lingering uncertainties persist due to the premature cessation of her chemotherapy.

Ilse Malfait at the Central World Sepsis Day Event in Berlin, 12 September 2023.

On 12 September 2023, Ilse spoke at the Central World Sepsis Day Event in Berlin, where she told her story to an international audience and called the Belgian government to action.

In November 2023, Ilse was featured in the documentary “Kwaad bloed” (Bad Blood) broadcasted by Belgian TV channel VRT. This documentary brought sepsis to the attention of the wider public and triggered a political debate, leading Belgian Minister for Health Frank Vandenbroucke to commission a report from Prof. Erika Vlieghe for a National Plan on Sepsis.

“Kwad bloed”, Pano, VRT.

This was a major success as only a few countries worldwide have implemented the World Health Assembly Resolution 70.7 on Sepsis, urging UN member states to integrate sepsis in their national health systems.

Ilse encapsulated her journey also in the book ‘Elk uur telt'‘ (Every Hour Counts), emphasizing the crucial need for swift intervention in septic shock.

Now, Ilse actively contributes to the cause by co-founding the non-profit organization SEPSIBEL, uniting sepsis survivors like Michael Clarke, whose story was already featured on our website. Their mission involves establishing a National Sepsis Plan with guidelines for early diagnosis and treatment. Ilse, along with the medical council, including Professor Erika Vlieghe and Professor Jan De Waele, President-Elect of the European Society of Intensive Care Medicine (ESICM), and collaborating organizations, endeavors to raise awareness among healthcare professionals and the general population about the symptoms and dangers of sepsis.

GSA founder Prof. Konrad Reinhart and GSA CEO Mariam Jashi with Ilse Malfait in Berlin, 12 September 2023.

Physically and mentally tired after three challenging years, Ilse remains resilient, driven by the urgency to implement the sepsis plan in Belgium. Her advocacy seeks to empower not only medical professionals but also the public, ensuring that the devastating impact of sepsis is met with prompt and informed responses.

The Global Sepsis Alliance and the European Sepsis Alliance are proud of the fight and the incredible achievements of Ilse Malfait. She is a true hero who can inspire millions of survivors and families affected by sepsis worldwide!

The GSA and the ESA stand ready to continuously support Ilse’s advocacy efforts and provide any necessary assistance to Belgian colleagues as they embark on developing the National Sepsis Plan.

Simone Mancini
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia

A recent randomized controlled trial authored by ESA President Prof Evangelos J Giamarellos-Bourboulis MD, PhD et al was published in Lancet Respiratory Medicine. In the study, 267 patients with community-acquired pneumonia were randomized to treatment either with clarithromycin and standard-of-care antibiotics or placebo and standard-of-care antibiotics. Clarithromycin treatment provided enhanced anti-inflammatory benefit the first 72 hours after randomization. Benefit from clarithromycin treatment was further expanded to reduction of risk of progression to organ dysfunction and secondary sepsis. Clinical benefit was associated with reversal of the complex immune dysregulation of community-acquired pneumonia. 

Please access the study for free via the button below until 21 February.

Simone Mancini